Methanex vs BASF: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Methanex Corporation (MEOH)

Q3 202629 Jun – 1 Sep 2026

▲2▼2

Methanex idles plants as gas shortages bite, but record profits cushion the blow

Titan plant in Trinidad idled indefinitely Methanex is shutting its Titan methanol plant in Trinidad for good because it could not secure a new natural gas contract. This removes 860,000 tonnes of yearly production, a real hit to future supply and earnings, though the plant is preserved for a possible restart.
This is a major new supply loss that directly reduces Methanex's production capacity and future revenue.
Record Q2 profit and cash flow Methanex reported record quarterly earnings: $198 million profit, $577 million adjusted EBITDA, and revenue up 75% to $1.4 billion. Strong methanol prices and record North American output let it repay debt and return cash to shareholders, a clear boost to the stock.
This shows the company's core business is generating huge profits and cash, which supports the share price.
New Zealand plants to close, gas entitlements sold Methanex will sell its New Zealand gas contracts and idle its plants there by early 2027 because domestic gas supply keeps falling. This removes another production region, tightening the company's overall output and adding to worries about long-term supply.
This is a fresh, significant loss of production capacity that further reduces Methanex's future supply.
Oil price spike lifts energy shares U.S.-Iran strikes pushed oil above $75 and energy stocks up nearly 4%, with Methanex jumping 6.2% in a single day. Higher oil prices make methanol more competitive as a fuel and chemical feedstock, but this boost is tied to volatile geopolitics and may not last.
It explains a sharp short-term price move and the link between oil prices and methanol demand.

July 202629 Jun – 1 Sep 2026

▲2▼2

Methanex idles plants as gas shortages bite, but record profits cushion the blow

Titan plant in Trinidad idled indefinitely Methanex is shutting its Titan methanol plant in Trinidad for good because it could not secure a new natural gas contract. This removes 860,000 tonnes of yearly production, a real hit to future supply and earnings, though the plant is preserved for a possible restart.
This is a major new supply loss that directly reduces Methanex's production capacity and future revenue.
Record Q2 profit and cash flow Methanex reported record quarterly earnings: $198 million profit, $577 million adjusted EBITDA, and revenue up 75% to $1.4 billion. Strong methanol prices and record North American output let it repay debt and return cash to shareholders, a clear boost to the stock.
This shows the company's core business is generating huge profits and cash, which supports the share price.
New Zealand plants to close, gas entitlements sold Methanex will sell its New Zealand gas contracts and idle its plants there by early 2027 because domestic gas supply keeps falling. This removes another production region, tightening the company's overall output and adding to worries about long-term supply.
This is a fresh, significant loss of production capacity that further reduces Methanex's future supply.
Oil price spike lifts energy shares U.S.-Iran strikes pushed oil above $75 and energy stocks up nearly 4%, with Methanex jumping 6.2% in a single day. Higher oil prices make methanol more competitive as a fuel and chemical feedstock, but this boost is tied to volatile geopolitics and may not last.
It explains a sharp short-term price move and the link between oil prices and methanol demand.

Latest29 Jun – 1 Sep 2026

▲2▼2

Methanex idles plants as gas shortages bite, but record profits cushion the blow

Titan plant in Trinidad idled indefinitely Methanex is shutting its Titan methanol plant in Trinidad for good because it could not secure a new natural gas contract. This removes 860,000 tonnes of yearly production, a real hit to future supply and earnings, though the plant is preserved for a possible restart.
This is a major new supply loss that directly reduces Methanex's production capacity and future revenue.
Record Q2 profit and cash flow Methanex reported record quarterly earnings: $198 million profit, $577 million adjusted EBITDA, and revenue up 75% to $1.4 billion. Strong methanol prices and record North American output let it repay debt and return cash to shareholders, a clear boost to the stock.
This shows the company's core business is generating huge profits and cash, which supports the share price.
New Zealand plants to close, gas entitlements sold Methanex will sell its New Zealand gas contracts and idle its plants there by early 2027 because domestic gas supply keeps falling. This removes another production region, tightening the company's overall output and adding to worries about long-term supply.
This is a fresh, significant loss of production capacity that further reduces Methanex's future supply.
Oil price spike lifts energy shares U.S.-Iran strikes pushed oil above $75 and energy stocks up nearly 4%, with Methanex jumping 6.2% in a single day. Higher oil prices make methanol more competitive as a fuel and chemical feedstock, but this boost is tied to volatile geopolitics and may not last.
It explains a sharp short-term price move and the link between oil prices and methanol demand.

BASF SE (BAS.XETRA)

Q3 202630 Jun – 25 Sep 2026

▲2▼1

BASF's mixed Q3: asset sale, buyback, AI bet, but Rhine and EU risks

Coatings sale completed BASF finished selling its coatings business to Carlyle for €7.7bn, boosting cash, profit, and earnings per share while keeping a 40% stake. This strengthens the balance sheet and supports shareholder returns.
Major completed deal that directly improved financials and cash flow.
AI investment and buyback BASF invested $1.1bn in AI for medical plastics and started a €1bn share buyback. These moves aim to drive future growth and return cash to shareholders, signaling confidence.
New strategic investments and capital returns that could lift investor sentiment.
Rhine water and EU emissions risks Record-low Rhine water levels threaten production and raw-material supplies, while an EU emissions overhaul could raise costs. These factors create operational and regulatory uncertainty.
Key external risks that could disrupt operations and increase expenses.
Evonik takeover talks BASF proposed a €12bn takeover of Evonik, which could create a European chemicals giant, but talks are early and shares fell nearly 2% on integration and funding concerns.
Potential transformative deal with uncertain outcome and negative initial market reaction.

August 202629 Jul – 25 Sep 2026

▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.
This is the period's biggest positive fundamental news and directly supports the share price.
Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.
It shows a broad industry pricing upturn that directly benefits BASF's earnings.
Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.
This is a real operational risk that could hurt earnings and weigh on the stock.
Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.
This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

Latest29 Jul – 25 Sep 2026

▲2▼1

BASF beats on profit, buys back stock, faces Rhine risk, eyes Evonik

Q2 profit surge and €1bn buyback BASF's Q2 net income jumped to €4.14bn, helped by a €3.5bn gain from selling its Coatings unit. It kept its upgraded 2026 profit forecast and will start a €1bn share buyback in August, part of a €4bn plan. Buybacks reduce shares outstanding, which can lift the stock price.
This is the period's biggest positive fundamental news and directly supports the share price.
Polyurethane price hikes lift chemical margins BASF and rivals like Wanhua and Huntsman raised MDI and TDI prices in late July and August. BASF is the world's second-largest MDI producer. Higher selling prices for these key chemicals can boost revenue and profit margins, pushing the stock up.
It shows a broad industry pricing upturn that directly benefits BASF's earnings.
Low Rhine water threatens production and supplies The Rhine fell to record-low levels, disrupting barge shipping. BASF's CEO said some product supplies can't be fully secured and the risk of production interruptions rises weekly. BASF gets about 40% of raw materials via the river, so continued drought could raise costs and cut output.
This is a real operational risk that could hurt earnings and weigh on the stock.
Takeover proposal for Evonik BASF proposed buying rival Evonik, which has a €12bn enterprise value. A deal would create a €74bn-revenue European chemicals giant better able to compete with Chinese and US rivals. But talks are early and may fail; BASF shares fell nearly 2% on the news, reflecting integration and funding concerns.
This is the period's major strategic move, with both potential long-term benefits and near-term uncertainty for BASF's stock.

July 202630 Jun – 17 Jul 2026

▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.
This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.
New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.
A concrete new product launch that supports future revenue growth in a profitable segment.
AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.
Shows BASF investing in technology that may improve margins and competitiveness over time.
EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.
A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.

30 Jun – 17 Jul 2026

▲3▼1

BASF sells coatings, invests in AI, faces EU emissions overhaul

Coatings sale completed BASF finished selling its coatings unit to Carlyle for €7.7 billion, bringing in about €5.8 billion in cash and a one-time gain that lifts reported profit and earnings per share. It keeps a 40% stake in the new company, so it still shares in future upside.
This is the single biggest event of the period, directly boosting BASF's cash and reported earnings.
New bio-identical collagen launch BASF and Bota Biosciences launched a new lab-made collagen ingredient for personal care. It is a fresh product that could add sales in the higher-margin beauty ingredients market, showing BASF's push into specialty chemicals beyond basic plastics.
A concrete new product launch that supports future revenue growth in a profitable segment.
AI investment in medical plastics BASF is putting $1.1 billion into AI reactor technology for medical plastics, part of a broader $2.3 billion industry push. This could make production more efficient and open new high-value markets, though the payoff will take years.
Shows BASF investing in technology that may improve margins and competitiveness over time.
EU emissions trading overhaul The EU is revising its carbon permit system, which could raise costs for heavy polluters like BASF. BASF is lobbying for a slower pace, warning that strict rules risk pushing industry out of Europe. The final outcome is still uncertain, but tighter rules would weigh on profits.
A regulatory risk that could increase BASF's operating costs and affect its European competitiveness.